| Website | anaphoreinc.com |
| Category | BioTech |
| Phone | (858) 587-4815 |
| Employees | |
| Description | Protein therapeutics |
| Total | $24.3M |
| Unattributed, 1/08 5AM Ventures | $3.3M |
| Unattributed, 4/08 5AM Ventures Versant Ventures | $8M |
| Series A, 6/09 SR One Merck Serono Ventures 5AM Ventures Apposite Capital Versant Ventures | $13M |
Anaphore (formerly ImmunoNewCo) is developing a new class of protein therapeutics to address significant unmet medical needs for patients with serious or life-threatening diseases.